Fineqia International (CSE: FNQ), a Draper University, LLC company is creating tools to enable financial entrepreneurs to increase global value. This is part of the rapidly increasing trend of globalization. They have signed on to participate in the New Economy Network's Global Business Trends Accelerator, which leverages collaboration across industry verticals to promote the convergence of businesses and their users in the new economy. The company is also involved with the Social Innovation Lab, an initiative of Draper University focusing on social solutions for the public good.
Fineqia International, Inc. (OTCBB: $ FNQ), an international health care company, primarily focuses on global market opportunities for life sciences, cardiovascular products, dental care, specialty pharmaceuticals, biotechnology, and nutrition. They sell a variety of pharmaceutical products such as insulin, growth hormones, cholesterol, and transdermal patches for diabetes. They have formed a strategic alliance with Fresenius Pharmaceuticals N.V. (chief commercial officer: Dieter Roth), in which the two companies will work together on applications in the area of Nutrition, Science, and Biotechnology.
Frankfurt is a leading financial market organization and works in the domain of wealth management.
The company has a strong global presence. It manufactures and distributes pharmaceutical drugs in various countries including the United States, Europe, Japan, China, Russia, India, and Australia. Frank Frankfurt Incorporated owns a 10.6% stake in FNQ.
*This article is intended to be used for informational purposes only. Please consult your financial advisor for personal financial advice related to any organizations mentioned in our articles*